NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
Clinical Trials
41 trialsNCT04565665 2026-03-10
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05672355 2026-03-05
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 2 Recruiting
NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT05022446 2026-02-13
The Impact of COVID-19 on Pulmonary Procedures
M.D. Anderson Cancer Center
Recruiting
NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
NCT04500600 2026-01-20
Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Active not recruiting
NCT05102656 2025-11-17
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04551378 2025-10-21
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
M.D. Anderson Cancer Center
Recruiting
NCT04650178 2025-10-14
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
M.D. Anderson Cancer Center
Active not recruiting
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT05683353 2025-05-31
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
Peking University First Hospital
Active not recruiting
NCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated
NCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT05135650 2025-02-13
Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
Fred Hutchinson Cancer Center
Phase 1 Terminated
NCT06469138 2025-01-29
8479217
BerGenBio ASA
Phase 1 Completed
NCT05148806 2024-12-09
MELODY
Imperial College London
Completed
NCT05058339 2024-09-19
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
M.D. Anderson Cancer Center
Completed
NCT06482281 2024-07-03
COVID-19 and Childhood Cancer
Karolinska Institutet
Active not recruiting
NCT05422937 2024-05-22
SPLaT-19
Keele University
Completed
NCT04666025 2024-04-08
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Completed
NCT05465876 2024-04-04
PACE-CLL
Sunnybrook Health Sciences Centre
Phase 2 Withdrawn
NCT04776005 2024-01-03
COVIDVAC OH
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05803395 2023-11-28
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown
NCT05438498 2023-09-08
Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
MediMergent, LLC
Phase 3 Terminated
NCT04852796 2023-08-30
HEMVACO
Centre Hospitalier de Cornouaille
Completed
NCT04630015 2023-05-09
Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
University of California, San Francisco
Completed
NCT05393999 2023-04-24
SABRE
Imperial College Healthcare NHS Trust
Phase 2 Withdrawn
NCT04422470 2023-01-26
CHRONOS19
National Research Center for Hematology, Russia
Completed
NCT04352556 2022-09-23
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
Unknown
NCT04932967 2022-06-22
Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04951323 2022-05-18
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
University of Liege
Phase 3 Unknown
NCT04330261 2022-05-17
PERN-COVID-19
University of Calgary
Completed
NCT04743388 2022-04-11
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
National and Kapodistrian University of Athens
Unknown
NCT04760184 2022-02-08
AutoCOVID-19
Uppsala University
Completed
NCT04652505 2022-01-14
Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study
M.D. Anderson Cancer Center
Completed
NCT04878822 2021-09-13
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
Ospedale di Circolo - Fondazione Macchi
Unknown
NCT04419623 2021-05-12
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
Telios Pharma, Inc.
Phase 1 Completed
NCT04745416 2021-02-09
Clinical Characteristics of Patients With Leukemia and COVID-19
Hospital General de Mexico
Completed
NCT04544878 2020-09-10
CLOVIS
Bicetre Hospital
Unknown
NCT04392128 2020-09-04
HYACINTHE
Institut de cancérologie Strasbourg Europe
Phase 2 Withdrawn